Chinese firm to start trials of COVID drug proxalutamide in PH in November

  • 📰 inquirerdotnet
  • ⏱ Reading Time:
  • 15 sec. here
  • 2 min. at publisher
  • 📊 Qulity Score:
  • News: 9%
  • Publisher: 86%

Chinese biotech firm Kintor Pharmaceutical Limited plans to conduct clinical trials in the Philippines for its experimental drug for COVID-19 called proxalutamide that is also being developed to treat prostate and breast cancer, DOH said. | cgonzalesINQ

Philippines Headlines News

Philippines Latest News, Philippines Headlines

“Meron na pong nakasalang na magiging trial dito sa atin sa Pilipinas at they have identified the Lung Center of the Philippines for this.

They are currently processing the contract,” Health Undersecretary Maria Rosario Vergeire told an online media briefing.“Nandoon pa lang tayo sa contracting stage pero may nakalagay doon sa kanilang isinumite na protocol na they intend to start by November of this year,” Vergeire added.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 3. in PH
 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.

Similar News:You can also read news stories similar to this one that we have collected from other news sources.